Login
Toggle navigation
Videos
Categories
Trending
Dror Bashan, CEO, Protalix Biotherapeutics Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Protalix BioTherapeutics looks to commercialize its Fabry Disease therapy
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Victoria Gold: Achieving Records and Expanding Horizons in Yukon's Gold Mining Scene
00:10:00
Shibani Kurian Presents Kotak Focused Equity Fund: A Strategy for Select Focus Investing | Shibani Kurian, Head of Research & Equity Fund Manager, Kotak Mutual Fund
00:10:00
Bradley Langille, President & CEO, Director of GoGold Resources Inc, presents at Metals Investor Forum, renowned for hosting vetted companies with excellent management, strong financials, and promising properties, providing investors with direct access to
00:00:00
Anders Hultman, CEO, AroCell AB (publ)
00:10:00
Investor in the trenches supporting you to close enterprise|Jessica Lin,Co-Founder and General Partner,Work-Bench
00:10:00
Convergenze's Leadership on the EU Agenda at Ambrosetti Forum 2021 | Rosario Pingaro, CEO, Convergenze S.p.A .
00:10:00
Sberbank's Pandemic Impact and Future Outlook | Philippe Brassac, CEO, Crédit Agricole SA.
00:10:00
Debating the Patriot Act: National Security vs. Civil Liberties on Uncommon Knowledge|Jenny S. Martínez
00:10:00
BoxGroup: Spark. Scale. Succeed,Cultivating Innovation|Adam Rothenburg,Partner,BoxGroup
00:10:00
Inspiring Through Music and Grief: Christy Nockels' Journey | BlueTrust
00:10:00
operational and organizational improvements|Gavin Christensen,Founder & General Partner,Kickstart
00:10:00
Catalyst Metals: ASX Gold Producer's Solid Financial Performance and Volatile Costs